- Home
- MODV vs HLVX Comparison
MODV vs HLVX Comparison
Compare MODV & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- HLVX
- Stock Information
- Founded
- MODV 1996
- HLVX 2020
- Country
- MODV United States
- HLVX United States
- Employees
- MODV N/A
- HLVX N/A
- Industry
- MODV Transportation Services
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- MODV Consumer Discretionary
- HLVX Health Care
- Exchange
- MODV Nasdaq
- HLVX Nasdaq
- Market Cap
- MODV 81.8M
- HLVX 92.6M
- IPO Year
- MODV N/A
- HLVX 2022
- Fundamental
- Price
- MODV $5.05
- HLVX $1.83
- Analyst Decision
- MODV Buy
- HLVX Hold
- Analyst Count
- MODV 5
- HLVX 5
- Target Price
- MODV $18.20
- HLVX $2.33
- AVG Volume (30 Days)
- MODV 634.6K
- HLVX 176.5K
- Earning Date
- MODV 03-04-2025
- HLVX 03-19-2025
- Dividend Yield
- MODV N/A
- HLVX N/A
- EPS Growth
- MODV N/A
- HLVX N/A
- EPS
- MODV N/A
- HLVX N/A
- Revenue
- MODV $2,787,619,000.00
- HLVX N/A
- Revenue This Year
- MODV $3.37
- HLVX N/A
- Revenue Next Year
- MODV $2.71
- HLVX N/A
- P/E Ratio
- MODV N/A
- HLVX N/A
- Revenue Growth
- MODV 3.16
- HLVX N/A
- 52 Week Low
- MODV $3.64
- HLVX $1.55
- 52 Week High
- MODV $39.48
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- MODV 38.32
- HLVX 43.02
- Support Level
- MODV $5.73
- HLVX $1.67
- Resistance Level
- MODV $6.09
- HLVX $1.99
- Average True Range (ATR)
- MODV 0.60
- HLVX 0.08
- MACD
- MODV 0.35
- HLVX -0.00
- Stochastic Oscillator
- MODV 54.23
- HLVX 48.48
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.